Sage Journals: Discover world-class research

Retricted access

Research article

First published 2005-04

Evaluation of the Therapeutic Response to In-111-DTPA Octreotide-Based Targeted Therapy in Liver Metastatic Neuroendocrine Tumors According to CT/MRI/US Findings

Georgios Spyridon Limouris, Nikolaos Dimitropoulos, Dimitrios Kontogeorgakos [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2009-10

High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience

Grace Kong, Val Johnston, Shakher Ramdave [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2014-05

[ 111 In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy

Stefan E. Pool, Boen L.R. Kam, Gerben A. Koning [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1997-02

Evaluation of Immunological Mechanisms Mediating Thyroid-Associated Ophthalmopathy by Radionuclide Imaging Using the Somatostatin Analog 111 In-Octreotide

R. Moncayo, I. Baldissera, C. Decristoforo [...]

Thyroid®

Retricted access

Research article

First published 1999-01

Somatostatin Receptor Scintigraphy Before and After Treatment with Somatostatin Analogues in Patients with Thyroid Eye Disease

G.E. Krassas, A. Doumas, Th. Kaltsas [...]

Thyroid®

Retricted access

Research article

First published 1999-02

[ 111 In-DPTA-D-Phe 1 ] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma

M. Edgren, J.E. Westlin, K.M. Kälkner [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1998-05

Somatostatin Analogues in the Treatment of Thyroid Eye Disease

G.E. Krassas

Thyroid®

Retricted access

Research article

First published 2005-04

Differences in Biodistribution Between 99m Tc-Depreotide,111 In-DTPA-Octreotide,and 177 Lu-DOTA-Tyr 3 -Octreotate in a Small Cell Lung Cancer Animal Model

Anneli Schmitt, Peter Bernhardt, Ola Nilsson [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2000-02

Inhibition of Metabolic Activity in Papillary Thyroid Carcinoma by a Somatostatin Analogue

Richard J. Robbins, Robert H. Hill, Weiping Wang [...]

Thyroid®

Retricted access

Research article

First published 2004-04

99m Tc-EDDA/HYNIC-TOC in the Management of Medullary Thyroid Carcinoma

Maria Parisella, Calogero D'Alessandria, Bieke van de Bossche [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results